Showing 1-5 of 47 resources:
BHE & OM1 PARTNER TO DELIVER RHEUMATOLOGY REGISTRIES THROUGH IHD

Research-Grade, Analytic-Ready Rheumatology Data at Your Fingertips through the IHD Platform What would you do with rapid access to analytics and insights from hundreds of thousands of rheumatology patients? Bringing together the largest linked, longitudinal rheumatology condition registries with the industry-leading Instant Health Data (IHD) platform, OM1 and BHE join forces to deliver a powerful[…]

OM1 EXPANDS RHEUMATOLOGY CONDITIONS WITH SPECIALIZED DATA FOR LICENSING AND ADVANCED ANALYTICS

BOSTON, April 30, 2019 — OM1, a leading health outcomes, data and technology company today announced that its rheumatology registries, which track hundreds of thousands of patients longitudinally throughout the United States, are now available for direct licensing as well as studies and advanced analytics. The registries include: Rheumatoid Arthritis Systemic Lupus Erythematosus Sjögrens Giant[…]

ASSESSING REAL-WORLD DATA QUALITY: THE APPLICATION OF PATIENT REGISTRY QUALITY CRITERIA TO REAL-WORLD DATA AND REAL-WORLD EVIDENCE

Assessing Real-World Data Quality: The Application of Patient Registry Quality Criteria to Real-World Data and Real-World Evidence Richard E. Gliklich MD, Michelle B. Leavy, MPH Sage Journals, First Published March 27, 2019 The use of real-world data and real-world evidence to inform health care decisions is increasing. Yet, the variable quality of these data and[…]

OM1 RHEUMATOID ARTHRITIS REGISTRY REACHES MORE THAN 100,000 PATIENTS PROSPECTIVELY FOLLOWED WITH DEEP CLINICAL DATA

BOSTON, January 16, 2019 — OM1, a leading health outcomes, registries and technology company creating solutions to better understand, compare, and predict patient outcomes, today announced that its Rheumatoid Arthritis (RA) registry has reached more than 100,000 patients with deep clinical data and is available for licensing, studies and advanced analytics. RA is a chronic autoimmune[…]

1 2 3 10